QR Code

Cysteinyl-leukotrienes promote cutaneous Leishmaniasis control

Leishmaniasis is a neglected tropical parasitic disease with few approved medications. Cutaneous leishmaniasis (CL) is the most frequent form, responsible for 0.7 - 1.0 million new cases annually worldwide. Leukotrienes are lipid mediators of inflammation produced in response to cell damage or infec...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Letícia Paula Trajano Noronha, Monique Daiane Andrade Martins, Archimedes Barbosa Castro-Junior, Maria Luiza Thorstenberg, Laís Costa-Soares, Thuany Prado Rangel, Felipe Carvalho-Gondim, Bartira Rossi-Bergmann, Luiz Eduardo Baggio Savio, Claudio de Azevedo Canetti, Robson Coutinho-Silva
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Frontiers Media S.A. 2023-06-01
Rangatū:Frontiers in Cellular and Infection Microbiology
Ngā marau:
Leishmania amazonensis
cysteinyl-leukotrienes
cutaneous leishmaniasis (CL)
LTC4
LTD4
P2X7
Urunga tuihono:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1192800/full
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite